Comparison of oral and vaginal misoprostol for cervical ripening before evacuation of first trimester missed miscarriage

Saudi Medical Journal

Volumn 30, Issue 1, 2009, Pages 82-87

  Jabir, Maysoon M ^a   Smeet, Rania I ^a  

^a BAGHDAD TEACHING HOSPITAL   (Iraq)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; METRONIDAZOLE; MISOPROSTOL; NARCOTIC ANALGESIC AGENT; PLACEBO;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIARRHEA; DILATION AND EVACUATION; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG INDUCED HEADACHE; FEMALE; FIRST TRIMESTER PREGNANCY; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; POSTOPERATIVE CARE; PREGNANCY TERMINATION; RANDOMIZED CONTROLLED TRIAL; SPONTANEOUS ABORTION; UTERINE CERVIX DILATATION; UTERINE CERVIX RIPENING; VOMITING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, SPONTANEOUS; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; CERVIX UTERI; FEMALE; HUMANS; MISOPROSTOL; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROSPECTIVE STUDIES; VAGINA;

EID: 62849084125     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Grudzinskas JG. Miscarriage, ectopic pregnancy and trophoblastic disease. In: Edmonds DK, editor. Dewhurst's Textbook of Obstetrics and Gynaecology for Postgraduates. 6th edition. London (United Kingdom): Blackwell Science: 1999. p. 61-75.
2. Ballagh SA, Harris HA, Demasio K. Is curettage needed for uncomplicated incomplete abortion? Am J Obstet Gynecol 1998; 179: 1279-1282.
3. Induced abortion operations and their early sequelae. Joint study of the Royal College of General Practitioners and the Royal College of Obstetricians and Gynaecologists. J R. Coll Gen Pract 1985; 35: 175-180.
4. Lawson HW, Frye A, Atrash HK, Smith JC, Shulman HB, Ramick M. Abortion mortality in United States, 1972 through 1987. Am J Obstet Gynecol 1994; 171: 1365-1372.
5. El-Refaey H, Calder L, Weatley DN & Templeton A. Cervical priming with PGE1 analogues, misoprostol and Gemeprost. Lancet 1994; 343: 1207-1209.
6. Ho Pc, Negai Sw, Liu KL, Wong GCY, Lee SWH. Vaginal misoprostol compared with oral misoprostol in termination of 2nd trimester pregnancy. Obstet Gynecol 1997; 90: 753-738.
7. Jain JK, Mishell DR Jr. A comparison intravaginal misoprostol with prostaglandin E2 for termination of second-trimester pregnancy. N Engl J Med 1994; 331: 290-293.
8. Sanchez-Ramos L, Kaunitz AM, Wears RL, Delke I, Gaudier FL. Misoprostol for cervival ripening and labor induction: A meta analysis. Obstet Gynecol 1997; 89: 633-642.
9. Vimala N, Mittal S, Kumar S, Dadhwal V, Mehta S. Sublingual misoprostol before 1st trimester abortion: A comparative study using 2 doses regimens. Int J Gynaecol Obstet 2004; 87: 1-5.
10. Cakir L, Dilbaz B, Caliskan E, Dede FS, Dilbaz S, Haberal A. Comparison of oral and vaginal misoprostol for cervical ripening before manual vacuum aspiration of first trimester pregnancy under local anesthesia: A randomized placebo-controlled study. Contraception 2005; 71: 337-342.
11. Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997; 90: 88-91.
12. Tang OS, Schweer H, Seyberth HW, Lee SW, Ho PC. Pharmacokinetics of different routes administration of misoprostol. Hum Reprod 2002; 17: 332-336.
13. Tang OS, Chan CC, Ng EH. Lee SW, Ho PC. A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation. Hum Reprod 2003; 18: 2315-2318.
14. Chong YS, Chua S, Arulkumaran S. Sublingual misoprostol for first trimester termination of pregnancy: Safety concerns. Hum Reprod 2002; 17: 2777.
15. Fong YF, Singh K, Prasad RN. A comparative study using two dose regimens (200 microg of 400 microg) of vaginal misoprostol for pre-operative cervical dilatation to facilitate nulliparae. Br J Obstet Gynaecol 1998; 105: 413-417.
16. Bugalho A, Bique C, Almeida L, Bergström S. Application of vaginal misoprostol before cervical dilatation to facilitate firs-trimester pregnancy interruption. Obstet Gynecol 1994; 83: 729-731.
17. Platz-Christensen JJ, Nielsen S, Hamberger L. Is misoprostol the drug of choice for induced cervival ripening in early pregnancy termination? Acta Obstet Gynecol Scand 1995; 74: 809-812.
18. Ngai SW, Tang OS, Lao T. Ho PC, Ma HK. Oral misoprostol versus placebo for cervical dilatation before vacuum aspiration in first trimester pregnancy. Hum Reprod 1995; 10: 1220-1222.
19. Fiçicioǧlu C, Taşdemir M, Taşdemir S. Effect of vaginal misoprostol application for cervical softening in pregnancy interruption before ten weeks of gestation. Acta Obstet Gynecol Scand 1996; 75: 54-56.
20. Lawrie A, Penney G. Templeton A. A randomised comparison of oral and vaginal misoprostol for cervical priming before suction termination of pregnancy. Br J Obstet Gynaecol 1996; 103: 1117-1119.
21. Ashok PW, Hamoda H, Nathani F, Flett GM, Templeton A. Randomised controlled study comparing oral and vaginal misoprostol for cervical priming prior to surgical termination of pregnancy. BJOG 2003; 110: 1057-1061.
22. Cytotec (misiprostol) prescribing information. Physicians' Desk Reference. 47th ed. Montvale (New Jersey): Medical Economics Co. Inc.; 1993. p. 2251-2253.
23. Searle. Cytotec®, (misoprostol) product information form for the American Hospital Formulary Service. Skokie (IL); 1988.
24. Bebbington MW, Kent N, Lim K, Gagnon A, Delisle MF, Tessier F, et al. A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination. Am J Obstet Gynecol 2002; 187: 853-857.
25. Kaali SG, Szigetvari IA, Bartfai GS. The frequency and management of uterine perforations during first-trimester abortions. Am J Obstet Gynecol 1989; 161; 406-408.